From: Asymptomatic bacteriuria in type 2 Iranian diabetic women: a cross sectional study
 | Sensitive | Resistant | Sensitive | Resistant | Sensitive | Resistant | Sensitive | Resistant |
---|---|---|---|---|---|---|---|---|
 | E. Coli (14) | Staphylococcus Coagulase Negative (3) | Streptococcus Hemolyticus Group B (3) | Pseudomonas Auroginosa (3) | ||||
Amikacin | 8 | 6 | 3 | 0 | 2 | 1 | 1 | 2 |
Gentamicin | 8 | 6 | 2 | 1 | 2 | 1 | 1 | 2 |
Ciprofloxacin | 5 | 9 | 2 | 1 | 1 | 2 | 1 | 2 |
Cephalotin | 1 | 13 | 1 | 2 | 2 | 1 | 2 | 1 |
Ceftazidime | 5 | 9 | NT | NT | NT | NT | 1 | 2 |
Ceftriaxone | 0 | 1 | NT | NT | NT | NT | 1 | 2 |
Nitrofurantion | 11 | 3 | 2 | 1 | 1 | 2 | NT | NT |
Nalidixic acid | 4 | 10 | NT | NT | NT | NT | NT | NT |
Cotrimoxazole | 4 | 10 | 2 | 1 | 2 | 1 | NT | NT |
Tobramycin | NT* | NT | NT | NT | NT | NT | 1 | 2 |
Clindamycin | NT | NT | 2 | 1 | 2 | 1 | NT | NT |
Erythromycin | NT | NT | 1 | 2 | 2 | 1 | NT | NT |
Vancomycin | 1 | 0 | 2 | 1 | 2 | 1 | NT | NT |
Ceftizoxime | NT | NT | NT | NT | NT | NT | 0 | 3 |
Ampicillin | NT | NT | NT | NT | 3 | 0 | NT | NT |